Rachel Nice
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Genetics top 5%
- Inflammatory Bowel Disease
Papers in
-
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 3
- Genetics 8
- Inflammatory Bowel Disease 5
- Co-authors
- Mary Elizabeth Haskett (2 shared papers)Jungmeen Kim‐Spoon (1 shared paper)Gregory S. Longo (1 shared paper)Rebecca L. Stelter (1 shared paper)Tariq Ahmad (6 shared papers)Neil Chanchlani (6 shared papers)Nicholas Alexander Kennedy (5 shared papers)James Goodhand (6 shared papers)
- Journals
- Journal of Crohn s and Colitis (7 papers)The Lancet. Gastroenterology & hepatology (5 papers)Alimentary Pharmacology & Therapeutics (3 papers)Child Abuse & Neglect (2 papers)The Lancet Diabetes & Endocrinology (2 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Rachel Nice
32 papers receiving 2.0k citations
Rachel Nice's Hit Papers
Peers
Comparison fields: 5 of 114
- Infectious Diseases 519
- Genetics 713
- Immunology 260
- Biological Psychiatry 19
- Epidemiology 249
Countries citing papers authored by Rachel Nice
This map shows the geographic impact of Rachel Nice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Nice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Nice more than expected).
Fields of papers citing papers by Rachel Nice
This network shows the impact of papers produced by Rachel Nice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Nice. The network helps show where Rachel Nice may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel Nice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study Hit paper breakdown → | 2019 | 527 |
| 2 | A reference map of potential determinants for the human serum metabolome Hit paper breakdown → | 2020 | 331 |
| 3 | 2021 | 208 | |
| 4 | 2021 | 113 | |
| 5 | 2022 | 113 | |
| 6 | 2022 | 82 | |
| 7 | 2023 | 82 | |
| 8 | Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study Hit paper breakdown → | 2024 | 80 |
| 9 | 2022 | 64 | |
| 10 | 2022 | 52 | |
| 11 | 2023 | 49 | |
| 12 | 2021 | 37 | |
| 13 | 2012 | 34 | |
| 14 | 2022 | 33 | |
| 15 | 2021 | 30 | |
| 16 | 2022 | 29 | |
| 17 | 2012 | 27 | |
| 18 | 2020 | 23 | |
| 19 | 2019 | 21 | |
| 20 | 2020 | 16 |
About Rachel Nice
Rachel Nice is a scholar working on Infectious Diseases, Genetics, Endocrinology, Diabetes and Metabolism, Immunology and Oncology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), Inflammatory Bowel Disease (5 papers), COVID-19 Clinical Research Studies (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Bioinformatics and Genomic Networks (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Infectious Diseases (519 citations), Genetics (713 citations), Immunology (260 citations), Biological Psychiatry (19 citations) and Epidemiology (249 citations). Rachel Nice has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Mary Elizabeth Haskett, Jungmeen Kim‐Spoon, Gregory S. Longo, Rebecca L. Stelter, Tariq Ahmad, Neil Chanchlani, Nicholas Alexander Kennedy, James Goodhand, Timothy James McDonald and Claire Bewshea. Their work appears in journals such as Journal of Crohn s and Colitis, The Lancet. Gastroenterology & hepatology, Alimentary Pharmacology & Therapeutics, Child Abuse & Neglect and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.